HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.

Abstract
Biguanides, used for anti-diabetic drugs, bring more attention in cancer research for their beneficial effects. Phenformin is more potent than metformin. However its potential application as a anti-cancer regent is far behind metformin. In order to investigate any beneficial effect of combination of Phenformin and radiotherapy, non-small cell lung cancer cell lines A549 and H1299 were exposure under different dose of ionizing radiation with or without Phenformin. Results indicated Phenformin showed synergistic effect and could induce more cancer cell apoptosis and inhibition of tumor growth compared with ionizing radiation alone. Furthermore, this synergistic effect may be through different pathway according to cancer cell genotype background. Our results showed Phenformin induced AMPK activation in A549 but not H1299. However, Phenformin activated eIF2α in both cell lines. Our findings implicated Phenformin may be used as radiosensitizer for non-small cell lung cancer therapy.
AuthorsJia Wang, Shi'an Xia, Zhizhen Zhu
JournalCell biochemistry and biophysics (Cell Biochem Biophys) Vol. 71 Issue 2 Pg. 513-8 (Mar 2015) ISSN: 1559-0283 [Electronic] United States
PMID25312480 (Publication Type: Journal Article)
Chemical References
  • DNA-Binding Proteins
  • Elf2 protein, mouse
  • Radiation-Sensitizing Agents
  • Transcription Factors
  • Phenformin
  • AMP-Activated Protein Kinases
Topics
  • AMP-Activated Protein Kinases (metabolism)
  • Animals
  • Apoptosis (drug effects)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, radiotherapy)
  • Cell Line, Tumor
  • DNA-Binding Proteins (metabolism)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, radiotherapy)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Phenformin (pharmacology, therapeutic use)
  • Radiation-Sensitizing Agents (pharmacology, therapeutic use)
  • Transcription Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: